HB22-1015
Off-label Use Of Approved Drugs To Treat COVID-19
Concerning the ability of certain health-care providers to repurpose therapeutic drugs that have been approved by the federal food and drug administration for another purpose to provide treatment to individuals with COVID-19.
Session:
2022 Regular Session
Subjects:
Bill Summary
Health Care & Health Insurance
Professions & Occupations
The bill specifies that:
- A physician, physician assistant, or advanced practice registered nurse with prescriptive authority may prescribe and dispense, and a pharmacist may dispense, therapeutic drugs for off-label use, including hydroxychloroquine sulfate and ivermectin, to provide prophylaxis or outpatient (at-home) and inpatient (hospital) treatment to an individual with COVID-19; and
- This practice is not unprofessional conduct or otherwise grounds for discipline.
(Note: This summary applies to this bill as introduced.)